{
  "resourceType": "MedicationRequest",
  "id": "medrx0317",
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative: MedicationRequest\u003c/b\u003e\u003ca name\u003d\"medrx0317\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource MedicationRequest \u0026quot;medrx0317\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003eidentifier\u003c/b\u003e: id: 12345689 (use: OFFICIAL)\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: completed\u003c/p\u003e\u003cp\u003e\u003cb\u003eintent\u003c/b\u003e: order\u003c/p\u003e\u003ch3\u003eMedications\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eReference\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003e\u003ca name\u003d\"med0303\"\u003e \u003c/a\u003e\u003cblockquote\u003e\u003cp/\u003e\u003cp\u003e\u003ca name\u003d\"med0303\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Alemtuzumab 10mg/ml (Lemtrada) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"http://terminology.hl7.org/4.0.0/CodeSystem-v3-rxNorm.html\"\u003eRxNorm\u003c/a\u003e#1594660)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003cp\u003e\u003cb\u003esubject\u003c/b\u003e: \u003ca href\u003d\"patient-example-a.html\"\u003ePatient/pat1: Donald Duck\u003c/a\u003e \u0026quot;Donald DUCK\u0026quot;\u003c/p\u003e\u003cp\u003e\u003cb\u003eauthoredOn\u003c/b\u003e: 2015-01-15\u003c/p\u003e\u003cp\u003e\u003cb\u003erequester\u003c/b\u003e: \u003ca href\u003d\"practitioner-example-f007-sh.html\"\u003ePractitioner/f007: Patrick Pump\u003c/a\u003e \u0026quot;Simone HEPS\u0026quot;\u003c/p\u003e\u003ch3\u003eReasons\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eConcept\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eChronic Lymphoid Leukemia (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#92814006)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edose\u003c/b\u003e\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 1\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 2\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edosageInstruction\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003esequence\u003c/b\u003e: 3\u003c/p\u003e\u003cp\u003e\u003cb\u003etext\u003c/b\u003e: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/p\u003e\u003cp\u003e\u003cb\u003eadditionalInstruction\u003c/b\u003e: Rapidly increase dose until tolerated \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e, Administer on alternate days \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003etiming\u003c/b\u003e: Duration 12weeks, 3 per 1 weeks\u003c/p\u003e\u003cp\u003e\u003cb\u003eroute\u003c/b\u003e: Intravenous route (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#47625008)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003emethod\u003c/b\u003e: Inject - dosing instruction imperative (qualifier value) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#422145002)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/div\u003e"
  },
  "contained": [
    {
      "resourceType": "Medication",
      "id": "med0303",
      "code": {
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1594660",
            "display": "Alemtuzumab 10mg/ml (Lemtrada)"
          }
        ]
      }
    }
  ],
  "identifier": [
    {
      "use": "official",
      "system": "http://www.bmc.nl/portal/prescriptions",
      "value": "12345689"
    }
  ],
  "status": "completed",
  "intent": "order",
  "medication": {
    "reference": {
      "reference": "#med0303"
    }
  },
  "subject": {
    "reference": "Patient/pat1",
    "display": "Donald Duck"
  },
  "authoredOn": "2015-01-15",
  "requester": {
    "reference": "Practitioner/f007",
    "display": "Patrick Pump"
  },
  "reason": [
    {
      "concept": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "92814006",
            "display": "Chronic Lymphoid Leukemia (disorder)"
          }
        ]
      }
    }
  ],
  "dose": {
    "dosageInstruction": [
      {
        "sequence": 1,
        "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
        "additionalInstruction": [
          {
            "text": "Rapidly increase dose until tolerated"
          },
          {
            "text": "Administer on alternate days"
          }
        ],
        "timing": {
          "repeat": {
            "duration": 12,
            "durationUnit": "wk",
            "frequency": 3,
            "period": 1,
            "periodUnit": "wk"
          }
        },
        "route": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "47625008",
              "display": "Intravenous route (qualifier value)"
            }
          ]
        },
        "method": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "422145002",
              "display": "Inject - dosing instruction imperative (qualifier value)"
            }
          ]
        },
        "doseAndRate": [
          {
            "type": {
              "coding": [
                {
                  "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
                  "code": "ordered",
                  "display": "Ordered"
                }
              ]
            },
            "doseQuantity": {
              "value": 3,
              "unit": "mg",
              "system": "http://unitsofmeasure.org",
              "code": "mg"
            }
          }
        ]
      },
      {
        "sequence": 2,
        "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
        "additionalInstruction": [
          {
            "text": "Rapidly increase dose until tolerated"
          },
          {
            "text": "Administer on alternate days"
          }
        ],
        "timing": {
          "repeat": {
            "duration": 12,
            "durationUnit": "wk",
            "frequency": 3,
            "period": 1,
            "periodUnit": "wk"
          }
        },
        "route": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "47625008",
              "display": "Intravenous route (qualifier value)"
            }
          ]
        },
        "method": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "422145002",
              "display": "Inject - dosing instruction imperative (qualifier value)"
            }
          ]
        },
        "doseAndRate": [
          {
            "type": {
              "coding": [
                {
                  "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
                  "code": "ordered",
                  "display": "Ordered"
                }
              ]
            },
            "doseQuantity": {
              "value": 10,
              "unit": "mg",
              "system": "http://unitsofmeasure.org",
              "code": "mg"
            }
          }
        ]
      },
      {
        "sequence": 3,
        "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
        "additionalInstruction": [
          {
            "text": "Rapidly increase dose until tolerated"
          },
          {
            "text": "Administer on alternate days"
          }
        ],
        "timing": {
          "repeat": {
            "duration": 12,
            "durationUnit": "wk",
            "frequency": 3,
            "period": 1,
            "periodUnit": "wk"
          }
        },
        "route": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "47625008",
              "display": "Intravenous route (qualifier value)"
            }
          ]
        },
        "method": {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "422145002",
              "display": "Inject - dosing instruction imperative (qualifier value)"
            }
          ]
        },
        "doseAndRate": [
          {
            "type": {
              "coding": [
                {
                  "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type",
                  "code": "ordered",
                  "display": "Ordered"
                }
              ]
            },
            "doseQuantity": {
              "value": 30,
              "unit": "mg",
              "system": "http://unitsofmeasure.org",
              "code": "mg"
            }
          }
        ]
      }
    ]
  },
  "meta": {
    "tag": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code": "HTEST",
        "display": "test health data"
      }
    ]
  }
}